Q&A With Emmanuel Labourier From BMDx Consulting: Taking a Closer Look at Molecular Diagnostic Test for Thyroid Cancer

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and exclusivity to help patients get a better idea of their condition.

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and sensitivity to help patients get a better idea of their condition.

Emmanuel Labourier, PhD, discussed the importance of this test during the AACE's 24th Annual Scientific and Clinical Congress in Nashville. Labourier said the new test reduces the need for surgery "two or three fold."